Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma, a Single-Center, Nonrandomized Phase II Clinical Trial
Brief Summary:
This trial intends: 1.To evaluate the concentration of Chidamide in the serum and cerebral-spinal fluid of PTCL patients at certain time points after taking the medicine, to evaluate the pharmacokinetics of Chidamide in these patients and its CNS (central nervous system) distribution.
2. To evaluate the efficiency and safety of Chidamide in PTCL patients.